Suppr超能文献

嘌呤能信号在肝疾病中的作用。

Purinergic signaling in hepatic disease.

机构信息

Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Boulevard Juriquilla 3001, C.P. 76230, Juriquilla, Querétaro, México.

出版信息

Purinergic Signal. 2019 Dec;15(4):477-489. doi: 10.1007/s11302-019-09680-3. Epub 2019 Oct 1.

Abstract

Extracellular purines (ATP and adenosine) are ubiquitous intercellular messengers. During tissular damage, they function as damage-associated molecular patterns (DAMPs). In this context, purines announce tissue alterations to initiate a reparative response that involve the formation of the inflammasome complex and the recruitment of specialized cells of the immune system. The present review focuses on the role of the purinergic system in liver damage, mainly during the onset and development of fibrosis. After hepatocellular injury, extracellular ATP promotes a signaling cascade that ameliorates tissue alterations to restore the hepatic function. However, if cellular damage becomes chronic, ATP orchestrates an aberrant reparative process that results in severe liver diseases such as fibrosis and cirrhosis. ATP and adenosine, their receptors, and extracellular ectonucleotidases are mediators of unique processes that will be reviewed in detail.

摘要

细胞外嘌呤(ATP 和腺苷)是普遍存在的细胞间信使。在组织损伤时,它们作为损伤相关分子模式(DAMPs)发挥作用。在这种情况下,嘌呤会发出组织改变的信号,启动修复反应,其中涉及炎性小体复合物的形成和免疫系统的专门细胞的募集。本综述重点介绍了嘌呤能系统在肝损伤中的作用,主要是在纤维化的发生和发展过程中。在肝细胞损伤后,细胞外 ATP 促进信号级联反应,改善组织改变,恢复肝功能。然而,如果细胞损伤持续存在,ATP 会协调异常的修复过程,导致严重的肝脏疾病,如纤维化和肝硬化。ATP 和腺苷、它们的受体和细胞外核苷酸酶是独特过程的介质,我们将详细回顾这些过程。

相似文献

1
Purinergic signaling in hepatic disease.
Purinergic Signal. 2019 Dec;15(4):477-489. doi: 10.1007/s11302-019-09680-3. Epub 2019 Oct 1.
2
Purinergic signaling in liver disease.
Dig Dis. 2014;32(5):516-24. doi: 10.1159/000360498. Epub 2014 Jul 14.
3
Pathological roles of purinergic signaling in the liver.
J Hepatol. 2012 Oct;57(4):916-20. doi: 10.1016/j.jhep.2012.06.008. Epub 2012 Jun 16.
4
Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.
Am J Physiol Cell Physiol. 2014 May 1;306(9):C779-88. doi: 10.1152/ajpcell.00381.2013. Epub 2013 Dec 18.
5
Purine Release, Metabolism, and Signaling in the Inflammatory Response.
Annu Rev Immunol. 2019 Apr 26;37:325-347. doi: 10.1146/annurev-immunol-051116-052406. Epub 2019 Jan 24.
6
Introduction to Purinergic Signaling.
Methods Mol Biol. 2020;2041:1-15. doi: 10.1007/978-1-4939-9717-6_1.
7
Purinergic Signaling in Non-Parenchymal Liver Cells.
Int J Mol Sci. 2024 Aug 30;25(17):9447. doi: 10.3390/ijms25179447.
8
Extracellular ATP signaling and clinical relevance.
Clin Immunol. 2018 Mar;188:67-73. doi: 10.1016/j.clim.2017.12.006. Epub 2017 Dec 20.
9
Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review.
Purinergic Signal. 2021 Dec;17(4):649-679. doi: 10.1007/s11302-021-09816-4. Epub 2021 Sep 29.
10
The purinergic neurotransmitter revisited: a single substance or multiple players?
Pharmacol Ther. 2014 Nov;144(2):162-91. doi: 10.1016/j.pharmthera.2014.05.012. Epub 2014 Jun 2.

引用本文的文献

1
alleviates liver fibrosis via modulation of purine metabolism and NF-κB signaling pathway: insights from multi-omics analysis.
Front Pharmacol. 2025 Aug 1;16:1630927. doi: 10.3389/fphar.2025.1630927. eCollection 2025.
2
Paroxetine attenuated liver fibrosis in liver of bile duct ligated rats: role of P2X purinoreceptor.
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 23. doi: 10.1007/s00210-025-04278-6.
3
Purinergic signaling in liver disease: calcium signaling and induction of inflammation.
Purinergic Signal. 2025 Feb;21(1):69-81. doi: 10.1007/s11302-024-10044-9. Epub 2024 Sep 25.
4
Purinergic Signaling in Non-Parenchymal Liver Cells.
Int J Mol Sci. 2024 Aug 30;25(17):9447. doi: 10.3390/ijms25179447.
5
Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation.
J Inflamm Res. 2024 Mar 11;17:1589-1605. doi: 10.2147/JIR.S424384. eCollection 2024.
6
The role of Pannexin-1 channels, ATP, and purinergic receptors in the pathogenesis of HIV and SARS-CoV-2.
Curr Opin Pharmacol. 2023 Dec;73:102404. doi: 10.1016/j.coph.2023.102404. Epub 2023 Sep 19.
8
Examination of the role of necroptotic damage-associated molecular patterns in tissue fibrosis.
Front Immunol. 2022 Aug 30;13:886374. doi: 10.3389/fimmu.2022.886374. eCollection 2022.
9
Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI.
J Ethnopharmacol. 2022 Nov 15;298:115661. doi: 10.1016/j.jep.2022.115661. Epub 2022 Aug 21.

本文引用的文献

1
Wolfberry-Derived Zeaxanthin Dipalmitate Attenuates Ethanol-Induced Hepatic Damage.
Mol Nutr Food Res. 2019 Jun;63(11):e1801339. doi: 10.1002/mnfr.201801339. Epub 2019 Apr 10.
3
Synaptic Functions of Hemichannels and Pannexons: A Double-Edged Sword.
Front Mol Neurosci. 2018 Dec 4;11:435. doi: 10.3389/fnmol.2018.00435. eCollection 2018.
8
The P2X4 purinergic receptor regulates hepatic myofibroblast activation during liver fibrogenesis.
J Hepatol. 2018 Sep;69(3):644-653. doi: 10.1016/j.jhep.2018.05.020. Epub 2018 May 24.
9
The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis.
Hepatol Commun. 2017 Sep 26;1(9):957-972. doi: 10.1002/hep4.1084. eCollection 2017 Nov.
10
Distinct roles of ecto-nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in liver regeneration and fibrosis.
Purinergic Signal. 2018 Mar;14(1):37-46. doi: 10.1007/s11302-017-9590-3. Epub 2017 Nov 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验